Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shari Pilon-Thomas

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letterLaszlo Radvanyi, Shari Pilon-Thomas, Weiyi Peng, et al.
European Journal of Clinical Nutrition|September 3, 2020
Immunotherapy on acid: opportunities and challengesSultan Damgaci, Pedro M Enriquez-Navas, Shari Pilon-Thomas, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A virtual cohort framework with applications to adoptive cell therapy in bladder cancerHannah G Anderson, Sarah Bazargan, David J Nusbaum, et al.
Immunology|February 28, 2018
Hypoxia and acidosis: immune suppressors and therapeutic targetsSultan Damgaci, Arig Ibrahim-Hashim, Pedro M Enriquez-Navas, et al.
Plos One|April 26, 2018
T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma modelHao Liu, Amy Weber, Jennifer Morse, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2009
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regressionOlga Radkevich-Brown, Marie P Piechocki, Jessica B Back, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2013
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinomaTomar Ghansah, Nasreen Vohra, Kathleen Kinney, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Rethinking the immunotherapy numbers gameRebecca A Bekker, Mohammad U Zahid, Jennifer M Binning, et al.
Cancer Immunology Research|August 30, 2019
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell ActivityRana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumorsMacLean Hall, Hao Liu, Mokenge Malafa, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letterLaszlo Radvanyi, Shari Pilon-Thomas, Weiyi Peng, et al.
European Journal of Clinical Nutrition|September 3, 2020
Immunotherapy on acid: opportunities and challengesSultan Damgaci, Pedro M Enriquez-Navas, Shari Pilon-Thomas, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A virtual cohort framework with applications to adoptive cell therapy in bladder cancerHannah G Anderson, Sarah Bazargan, David J Nusbaum, et al.
Immunology|February 28, 2018
Hypoxia and acidosis: immune suppressors and therapeutic targetsSultan Damgaci, Arig Ibrahim-Hashim, Pedro M Enriquez-Navas, et al.
Plos One|April 26, 2018
T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma modelHao Liu, Amy Weber, Jennifer Morse, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2009
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regressionOlga Radkevich-Brown, Marie P Piechocki, Jessica B Back, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2013
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinomaTomar Ghansah, Nasreen Vohra, Kathleen Kinney, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Rethinking the immunotherapy numbers gameRebecca A Bekker, Mohammad U Zahid, Jennifer M Binning, et al.
Cancer Immunology Research|August 30, 2019
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell ActivityRana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, et al.
Journal for Immunotherapy of Cancer|October 26, 2016
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumorsMacLean Hall, Hao Liu, Mokenge Malafa, et al.
Pageof 11